Gemcitabine and docetaxel as a novel treatment regimen for blastic plasmacytoid dendritic cell neoplasm

Am J Hematol. 2017 May;92(5):E75-E77. doi: 10.1002/ajh.24696. Epub 2017 Mar 20.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Dendritic Cells*
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives
  • Disease-Free Survival
  • Docetaxel
  • Female
  • Gemcitabine
  • Hematologic Neoplasms / drug therapy*
  • Hematologic Neoplasms / mortality*
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Survival Rate
  • Taxoids / administration & dosage

Substances

  • Taxoids
  • Deoxycytidine
  • Docetaxel
  • Gemcitabine